.jpg)
Combination hormone therapy increases the risk of heart diseases in the post menopause period among women, analyses the Women's Health Initiative (WHI).
After re-analyzing the facts, Harvard School of Public Health and National Heart, Lung and Blood Institute concluded that the effects of combination hormone therapy, specially progestin in combination with estrogen, results in heart attacks.
The average age of menopause is 50 years. For several years before menopause, women face irregular periods and develop hot flashes, night sweats and vaginal dryness. Post menopausal hormonal therapy is an option to ease the symptoms of menopause. Estrogen is the most beneficial and common for of hormone therapy.
"Women who opt for hormonal therapy within 10 years of menopause have an elevated risk of heart attacks," says Dr. Susan B. Shurin, Acting Director of the National Heart, Lung, and Blood Institute.
Women opting for hormone therapy, post menopause, should discuss the risks of heart diseases, breast cancer, and blood clots with their doctors before starting the therapy.
After re-analyzing the facts, Harvard School of Public Health and National Heart, Lung and Blood Institute concluded that the effects of combination hormone therapy, specially progestin in combination with estrogen, results in heart attacks.
The average age of menopause is 50 years. For several years before menopause, women face irregular periods and develop hot flashes, night sweats and vaginal dryness. Post menopausal hormonal therapy is an option to ease the symptoms of menopause. Estrogen is the most beneficial and common for of hormone therapy.
"Women who opt for hormonal therapy within 10 years of menopause have an elevated risk of heart attacks," says Dr. Susan B. Shurin, Acting Director of the National Heart, Lung, and Blood Institute.
Women opting for hormone therapy, post menopause, should discuss the risks of heart diseases, breast cancer, and blood clots with their doctors before starting the therapy.
0 Comments:
Post a Comment